Literature DB >> 1086415

[Reflux esophagitis (author's transl)].

M Allgöwer, R Siewert.   

Abstract

The term "Refluxdisease" consider an esophageal response (either subjective or objective) to injury caused by gastrointestinal contents. Thickening of the basal layer of the esophageal mucosa, reflux esophagitis, endobrachyesophagus, acquired short esophagus and peptic stenosis are different stages of the objective esophageal response. The diagnosis of reflux disease must take account of these findings where appropriated. The various stages of reflux disease can only by recognized and adequately treated following an exact diagnosis that takes into account as may parameters as possible. For this reason fundoplication, which is at present the most effective procedure, should only be performed when the indications are particularly strong.

Entities:  

Mesh:

Year:  1976        PMID: 1086415     DOI: 10.1007/bf01254578

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  6 in total

1.  Fundoplication for treatment of hiatal hernia.

Authors:  M Rossetti; M Allgöwer
Journal:  Prog Surg       Date:  1973

2.  [Experimental and clinical tests on the mechanism of fundoplication].

Authors:  R Siewert; H M Jennewein; F Waldeck; H J Peiper
Journal:  Langenbecks Arch Chir       Date:  1973-06-29

Review 3.  [Diagnostic and therapeutic problems following surgery of the esophagus].

Authors:  M Wienbeck; R Siewert
Journal:  Internist (Berl)       Date:  1976-06       Impact factor: 0.743

Review 4.  Pathophysiology and diagnosis of reflux esophagitis.

Authors:  C E Pope
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Medical and surgical management of reflux esophagitis. A 38-month report of a prospective clinical trial.

Authors:  J Behar; D G Sheahan; P Biancani; H M Spiro; E H Storer
Journal:  N Engl J Med       Date:  1975-08-07       Impact factor: 91.245

6.  Complications of vagotomy in the treatment of hiatal hernia.

Authors:  J H Vansant; J W Baker
Journal:  Ann Surg       Date:  1976-06       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.